Epigenetic control of podocyte differentiation: a new target of the renin–angiotensin system in kidney disease
Author:
- 1 October 2015
- journal article
- editorial
- Published by Elsevier in Kidney International
- Vol. 88 (4) , 668-670
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuriaKidney International, 2015
- The cell biology of renal filtrationJournal of Cell Biology, 2015
- Epigenetic repression of Krüppel-like factor 4 through Dnmt1 contributes to EMT in renal fibrosisInternational Journal of Molecular Medicine, 2015
- KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuriaJournal of Clinical Investigation, 2014
- Glomerular mRNA Expression of Prothrombotic and Antithrombotic Factors in Renal Transplants With Thrombotic MicroangiopathyTransplantation, 2013
- UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9Nature Communications, 2013
- MG98, a Second-Generation DNMT1 Inhibitor, in the Treatment of Advanced Renal Cell CarcinomaCancer Investigation, 2012
- Transcription of nephrin-Neph3 gene pair is synergistically activated by WT1 and NF- B and silenced by DNA methylationNephrology Dialysis Transplantation, 2011
- Antiproteinuric effect of RAS blockade: New mechanismsCurrent Hypertension Reports, 2004